Efficacy and safety of vildagliptin and voglibose in Japanese patients with type 2 diabetes: a 12‐week, randomized, double‐blind, active‐controlled study - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of vildagliptin and voglibose in Japanese patients with type 2 diabetes: a 12‐week, randomized, double‐blind, active‐controlled study

DOI Full Paper Access

72

Citations

18

References

2010

Year

Yasuhiko Iwamoto, Atsunori Kashiwagi, N Yamada, Shinji Terao, Nobuyuki Mimori, Manabu Suzuki, Hiromi Tachibana

Diabetes Obesity and Metabolism

Abstract

Vildagliptin (50 mg bid) showed superior efficacy and better tolerability compared with voglibose in Japanese patients with T2D.

References

	Year	Citations

Page 1